In the medical field, antibacterial drugs are a powerful weapon against bacterial infections, but if used inappropriately, they can become a double-edged sword. The correct use of anti-bacterial drugs is a matter of concern to each of us.
The first criterion for the use of anti-bacterial drugs is the explicit indication of their use. Antibacterial drugs are not universal and they are effective only for bacterial infections and do nothing for virus-induced diseases such as flu and influenza. In many cases, symptoms such as fever and cough do not necessarily mean bacterial infection. It is therefore essential that, prior to the use of anti-bacterial drugs, it be determined, through a professional diagnosis by a doctor, a combination of symptoms, signs and the results of laboratory examinations, that the bacterial infection be found and that the drug not be used blindly by self-perception alone.
Precision in the selection of antibacterial drugs depends on the determination of pathogens and drug sensitivity tests. Before the drug is used, as far as possible, samples of the patient ‘ s blood, sluice, urine, etc. should be collected for pathological examinations and drug-sensitive tests. This is like making “images” of pathogens, specifying which bacteria are disrupting and which drugs they are sensitive to. This allows doctors to be targeted, to select the most targeted and effective antibacterial drugs for patients, and to significantly increase the success rate of treatment while avoiding unnecessary drug testing.
Reasonable choice of medicines also requires that the individual differences of the patient be taken into account. The tolerance and response to drugs varies among patients of different ages and health conditions. For example, children ‘ s liver and kidney functions are not fully developed and the organs of older persons are declining, and their use of antibacterial drugs requires fine-tuning of their type, dose and course of treatment. In cases where the liver and kidney function is incomplete, those substances that may increase the liver and kidney burden should be used with caution or avoided in order to prevent further damage to the body.
The development of drug programmes is equally critical. This covers various aspects of the dose, route, frequency and course of treatment. The determination of the dose is like a wire that is too small to effectively kill bacteria, and may also lead to bacteria producing drug resistance and burying the hazard for subsequent treatment; too much exposes the patient to a greater risk of adverse reactions. The choice of the drug route is also highly academic, and it may be necessary for an intravenous drip to make the drug work quickly when the condition is critical, while the need may be met by oral delivery at a lighter time. The treatment is designed to be even more inimical, and it is generally necessary to continue to use drugs for a period of time after the patient ‘ s symptoms have disappeared, to ensure that bacteria are completely eliminated and that re-emerging infections are eliminated.
Co-medicines need to be treated with caution in antibacterial treatment. While the joint use of multiple antibacterial drugs can sometimes expand antibacterial spectrometry and enhance therapeutic efficacy, this is by no means a routine operation. Co-medicine use is considered only in the face of a specific situation, such as a serious disease with unknown cause, a combination of infection beyond the control of a single drug, and is generally appropriate for a combination of two and, in exceptional cases, up to three. In the case of joint drug use, the interaction between drugs is complex and strict principles need to be followed in order to avoid overloading or offsetting the effects of adverse reactions.
The use of anti-bacterial drugs is more strictly controlled for preventive use. Preventive use of antibacterial drugs is limited to specific situations, such as surgical prevention of oral infections. In everyday life, anti-bacterial drugs must not be used at random in order to prevent disease, and this unwarranted preventive drug can only contribute to the growth of bacterial resistance, leaving us without drugs when we are actually facing bacterial infections.
Close observation of therapeutic effects and adverse reactions is essential throughout the treatment process. Patients and doctors are aware of the changes in symptoms, signs and, if treatment is found to be ineffective, such as continued fever and no reduction in infection symptoms, it is necessary to adjust the programme in a timely manner. At the same time, there is a constant vigilance against possible adverse effects of drugs, such as gastrointestinal disorders, allergies, etc. In the event of a negative reaction, measures should be taken in accordance with the severity of the reaction, with minor adverse effects being treated under the direction of a doctor and, in the event of serious cases, with an immediate stoppage and emergency treatment.
Lastly, it was important to follow medical instructions. Antibacterial drugs are mostly prescription drugs, which means that there are significant risks to self-purchase and use. Patients are required to take drugs on time, on the same scale and according to the procedure, in strict accordance with the prescription prescribed by the doctor, and are not allowed to reduce the dose, change the usage or stop the medication.
Antibacterial drugs are the custodians of human health, but only when we use them properly can they play the greatest role in creating a strong health line for us, away from the threat of bacterial infection, while delaying the generation of bacterial resistance and preserving effective antibacterial treatment for future generations.
